Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Scope of the Report:
The classification of artificial heart lung machines includes single roller pump HLM and double roller pump HLM, and the revenue proportion of single roller pump HLM in 2016 is about 66.3%. Artificial heart lung machines can be used for cardiac surgery, lung transplant operation, acute respiratory failure treatment and other. The most proportion of artificial heart lung machines is used for cardiac surgery, and the sales proportion is about 66.2% in 2016.
North America is the largest sales place, with a sales market share nearly 36.4% in 2016. Following North America, Europe is the second largest sales place with the sales market share of 33.3%. China, Japan and Korea are also important sales regions for artificial heart lung machines.
Heart Lung Machine market is mainly occupied by large companies, Sorin as the largest player in the market produced over 57% of Artificial Heart Lung Machine and made more than 59.6% of revenue share in 2016. MAQUET followed as second produced about 18.3% in 2016.
The worldwide market for Artificial Heart Lung Machines is expected to grow at a CAGR of roughly 4.0% over the next five years, will reach 310 million US$ in 2024, from 250 million US$ in 2019, according to a new study.
This report focuses on the Artificial Heart Lung Machines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
LivaNova (Sorin)
Getinge (Maquet)
Medtronic
Terumo CV Group
Braile Biomedica
Tianjin Medical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Single Roller Pump HLM
Double Roller Pump HLM
Market Segment by Applications, can be divided into
Cardiac Surgery
Lung Transplant Operation
Acute Respiratory Failure Treatment
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Artificial Heart Lung Machines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Artificial Heart Lung Machines, with price, sales, revenue and global market share of Artificial Heart Lung Machines in 2017 and 2018.
Chapter 3, the Artificial Heart Lung Machines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Artificial Heart Lung Machines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Artificial Heart Lung Machines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Artificial Heart Lung Machines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Scope of the Report:
The classification of artificial heart lung machines includes single roller pump HLM and double roller pump HLM, and the revenue proportion of single roller pump HLM in 2016 is about 66.3%. Artificial heart lung machines can be used for cardiac surgery, lung transplant operation, acute respiratory failure treatment and other. The most proportion of artificial heart lung machines is used for cardiac surgery, and the sales proportion is about 66.2% in 2016.
North America is the largest sales place, with a sales market share nearly 36.4% in 2016. Following North America, Europe is the second largest sales place with the sales market share of 33.3%. China, Japan and Korea are also important sales regions for artificial heart lung machines.
Heart Lung Machine market is mainly occupied by large companies, Sorin as the largest player in the market produced over 57% of Artificial Heart Lung Machine and made more than 59.6% of revenue share in 2016. MAQUET followed as second produced about 18.3% in 2016.
The worldwide market for Artificial Heart Lung Machines is expected to grow at a CAGR of roughly 4.0% over the next five years, will reach 310 million US$ in 2024, from 250 million US$ in 2019, according to a new study.
This report focuses on the Artificial Heart Lung Machines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
LivaNova (Sorin)
Getinge (Maquet)
Medtronic
Terumo CV Group
Braile Biomedica
Tianjin Medical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Single Roller Pump HLM
Double Roller Pump HLM
Market Segment by Applications, can be divided into
Cardiac Surgery
Lung Transplant Operation
Acute Respiratory Failure Treatment
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Artificial Heart Lung Machines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Artificial Heart Lung Machines, with price, sales, revenue and global market share of Artificial Heart Lung Machines in 2017 and 2018.
Chapter 3, the Artificial Heart Lung Machines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Artificial Heart Lung Machines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Artificial Heart Lung Machines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Artificial Heart Lung Machines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
